Clinical Trial Update: Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients

View source ↗

Summary

This update describes ongoing development of a molecular diagnostic platform to monitor oral hygiene in patients with diabetes, sponsored by General Biologicals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Periodontal Disease

Snippet

Sponsor: General Biologicals Corporation | Conditions: Diabetes Mellitus, Periodontal Diseases | Status: UNKNOWN